Abundis MEE, Yeverino CSG, Muñoz DAC, Villarreal MDZ, Torres QFJ, Serna PG, Ocampo CJ, Salinas MR, Morales DR

Language: English
References: 14
Page: 20-23
PDF size: 159.28 Kb.

ABSTRACT

Dermatomyositis (DM) is an idiopathic inflammatory disease that causes symmetrical proximal muscle weakness and skin involvement primarily observed in individuals aged forty to fifty. Within the disease’s subtypes is amyopathic DM, which is a rare and complex syndrome that represents approximately 10% of dm cases.
We present an unusual case of amyopathic dermatomyositis subtype in a 77-year-old woman with multiple comorbidities and a history of dermatosis nine years earlier with the diagnostic criteria for this disease.

REFERENCES

1. Bailey EE and Fiorentino DF. Amyopathic dermatomyositis:definitions, diagnosis, and management, Curr Rheumatol Rep 2014; 16(12):1-2. Available from: https://pubmed.ncbi.nlm.nih.gov/25366932/.

2. DeWane ME, Waldman R and Lu J, Dermatomyositis: clinicalfeatures and pathogenesis, J Am Acad Dermatol 2020;82(2):267-81. Available from: https://pubmed.ncbi.nlm.nih.gov/31279808/.

3. Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, Michon-Pasturel U et al., Influence of age on characteristics of polymyositisand dermatomyositis in adults. Medicine (Baltimore)1999; 78(3):139-47. Available from: https://pubmed.ncbi.nlm.nih.gov/10352646/.

4. Concha JSS, Tarazi M, Kushner CJ, Gaffney RG and Werth VP,The diagnosis and classification of amyopathic dermatomyositis:a historical review and assessment of existing criteria, Br JDermatol 2019; 180(5):1001-6. Available from: https://pubmed.ncbi.nlm.nih.gov/10226772/.

5. Rodríguez-Tejero A, López-Espadafor B, Montero-Vílchez T, Sánchez-Díaz M, Arias-Santiago S and Molina-Leyva A, Treatmentchallenges in clinically amyopathic dermatomyositis: a caseseries and review of new therapeutic options for skin involvement,Dermatol Ther 2021; 34(3):1-4.

6. Gerami P, Schope JM, McDonald L, Walling HW and SontheimerRD, A systematic review of adult-onset clinically amyopathicdermatomyositis (dermatomyositis sine myositis): a missinglink within the spectrum of the idiopathic inflammatory myopathies,J Am Acad Dermatol 2006; 54(4):602-3.

7. Flores-Suárez LF, Morales H, Ángeles A and Kraus A, Druginducedamyopathic dermatomyositis, J Clin Rheumatol2002; 8(1):50-4. Available from: https://pubmed.ncbi.nlm.nih.gov/17039201/.

8. Tang K, Zhang H and Jin H, Clinical characteristics and managementof patients with clinical amyopathic dermatomyositis:a retrospective study of 64 patients at a tertiary dermatologydepartment, Front Med (Lausanne) 2021; 8:1-4. Available from:https://www.frontiersin.org/.

9. Callander J, Robson Y, Ingram J and Piguet V. Treatment of clinicallyamyopathic dermatomyositis in adults: a systematic review,Br J Dermatol 2018; 179(6):1248-9. Available from: https://pubmed.ncbi.nlm.nih.gov/27167896/.

10. Da Silva DM, Patel B and Werth VP, Dermatomyositis: a diagnosticdilemma, J Am Acad Dermatol 2018; 79(2):372-3. Availablefrom: https://www.jaad.org/article/S0190962218300173/fulltext.

11. Suárez-Ortega S, Puente-Fernández A, Santana-Báez S, Godoy-Díaz D, Serrano-Fuentes M and Sanz-Peláez O, Constitutionalsyndrome: clinical entity or a mixed bag, Rev Med Inst MexSeguro Soc 2013; 51(5):532-5.

12. Martone AM, Onder G, Vetrano DL, Ortolani E, Tosato M, MarzettiE et al., Anorexia of aging: a modifiable risk factor for frailty,Nutrients 2013; 5(10):4126-30. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820063/.

13. Christopher-Stine L, Vleugels RA and Amato AA, Clinical manifestationsof dermatomyositis and polymyositis in adults, 2024.Available from: https://medilib.ir/uptodate/show/5159.

14. Hu T and Vinik O, Dermatomyositis and malignancy, CanadianFamily Physician 2019; 65(6):409-10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738379/.